Antibody-drug conjugates (ADCs) stand at the forefront of innovative biotherapeutic agents, representing a rapidly emerging class of...
Overcoming Challenges in ADC Purification: A Case Study
Case study: Purification of an ADC to remove the residual free drug Among bioconjugates, antibody-drug conjugates (ADCs) represent a...
Why Choosing a Client-Centric CDMO for the Manufacturing of Your Biologics is Critical to the Success of Your Project?
In the rapidly evolving landscape of biopharmaceutical development, finding the right Contract Development and Manufacturing Organization...
Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19
Case study: Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19 When...
Antibody-Drug Conjugates (ADC) and their potential therapeutic applications
In the dynamic landscape of therapeutic development, antibody-drug conjugates (ADCs) have emerged as a ground-breaking class of...
A review of the therapeutic use of monoclonal antibodies
Therapeutic monoclonal antibodies (mAbs) have become a dominant product class within the biopharmaceutical market. To date, therapeutic...
Key considerations for biologics CDMO tech transfer
A technology transfer (or CDMO tech transfer) consists in transferring process knowledge from development to manufacturing or between...
What are monoclonal antibodies and their therapeutic applications?
What are monoclonal antibodies and their therapeutic applications? Monoclonal antibodies (mAbs) constitute a significant achievement in...